Baxter International Inc. BAX
- Market cap
- $12.2B
- P/E
- 0.0×
Follow BAX
Baxter International Inc. (BAX) Price to free cash flow
As of 25 September 2026, Baxter International Inc. (BAX) trades at a price to free cash flow of 14.8×. Over the past ten years it has ranged from 7.6× (September 2015) to 85.5× (March 2025); the current reading is higher than 12% of that period. That is below the Medical Instruments & Supplies industry median of 25.7× and below the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 29.5× | 13.77% |
| FY2024 | 26.0× | 70.84% |
| FY2023 | 15.2× | (50.75%) |
| FY2022 | 30.8× | 9.59% |
| FY2021 | 28.1× | (20.13%) |
| FY2020 | 35.2× | 16.57% |
| FY2019 | 30.2× | 16.80% |
| FY2018 | 25.9× | (22.08%) |
| FY2017 | 33.2× | 28.00% |
| FY2016 | 26.0× | 6.95% |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 13.5× | 13.02% |
| Mar 2026 | 12.0× | (59.47%) |
| Dec 2025 | 29.5× | (38.44%) |
| Sep 2025 | 48.0× | (26.82%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| STVN Stevanato Group S.p.A. compare | n/m |
| SOLV Solventum Corporation compare | n/m |
| BAX Baxter International Inc. | 14.8× |
| ALGN Align Technology, Inc. compare | 15.5× |
| COO The Cooper Companies, Inc. compare | 15.8× |
| AVTR Avantor, Inc. compare | 22.7× |
| ATR AptarGroup, Inc. compare | 25.1× |
| BLCO Bausch + Lomb Corporation compare | 53.9× |
| RGEN Repligen Corporation compare | 175× |
| Medical Instruments & Supplies industry median | 25.7× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on BAX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement